Dominique Custeau

Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4<i>H</i>-chromenes, a novel series of anticancer agents

Henriette Gourdeau, Lorraine Leblond, Bettina A. Hamelin et al. · Molecular Cancer Therapeutics · 2004 · 289 citations

Medicine, Medicinal Chemistry, Pharmacology +14

The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain.

Yiai Tong, Quan Yang, Carol A. Vater et al. · PubMed · 2001 · 42 citations

Life Sciences, Cell Biology, Oncology +17

Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity

Henriette Gourdeau, Lucie Bibeau, France Ouellet et al. · Cancer Chemotherapy and Pharmacology · 2001 · 41 citations

Medicine, Oncology, Pharmacology +17

Species Differences in Troxacitabine Pharmacokinetics and Pharmacodynamics

Henriette Gourdeau, Lorraine Leblond, Bettina A. Hamelin et al. · Clinical Cancer Research · 2004 · 18 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovery of 1-((6-Aminopyridin-3-yl)Methyl)-3-(4-Bromophenyl)Urea as a Potent, Irreversible Myeloperoxidase Inhibitor

Martı́n L. Marro, Andrew W. Patterson, Lac Lee et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 13 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15